Advertisement
Screener

Zoetis Inc. (ZTS) APIC, Share-based Payment Arrangement, Increase for Cost Recognition

3.0 / 5 stars · 73/120 Roast Me

Zoetis Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition

Zoetis Inc. (ZTS) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $26.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital

us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-06

  • Zoetis Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $26.00M, a 0.00% change year-over-year.
  • Zoetis Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $13.00M, a 550.00% increase year-over-year.
  • Zoetis Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was $23.00M, a 15.00% increase year-over-year.
  • Zoetis Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $22.00M, a 15.79% increase year-over-year.
  • Zoetis Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $73.00M, a 12.31% increase from fiscal 2024.
  • Zoetis Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $65.00M, a 26.14% decline from fiscal 2023.
  • Zoetis Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $88.00M, a 282.61% increase from fiscal 2022.
  • Zoetis Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $23.00M, a 15.00% increase from fiscal 2021.
Period endAPIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 monthAPIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 monthAPIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 monthAPIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month
2026-06-30$26.00M
10-Q · filed 2026-08-06
$39.00M
10-Q · filed 2026-08-06
$62.00M
derived: sum of 3 quarters · filed 2026-08-06
$84.00M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$13.00M
10-Q · filed 2026-05-07
$36.00M
derived: sum of 2 quarters · filed 2026-05-07
$58.00M
derived: sum of 3 quarters · filed 2026-05-07
$84.00M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$23.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
$45.00M
derived: sum of 2 quarters · filed 2026-02-12
$71.00M
derived: sum of 3 quarters · filed 2026-08-06
$73.00M
10-K · filed 2026-02-12
2025-09-30$22.00M
10-Q · filed 2025-11-04
$48.00M
derived: sum of 2 quarters · filed 2026-08-06
$50.00M
10-Q · filed 2025-11-04
$70.00M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$26.00M
10-Q · filed 2026-08-06
$28.00M
10-Q · filed 2026-08-06
$48.00M
derived: sum of 3 quarters · filed 2026-08-06
$67.00M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$2.00M
10-Q · filed 2026-05-07
$22.00M
derived: sum of 2 quarters · filed 2026-05-07
$41.00M
derived: sum of 3 quarters · filed 2026-05-07
$63.00M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$20.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
$39.00M
derived: sum of 2 quarters · filed 2026-02-12
$61.00M
derived: sum of 3 quarters · filed 2026-02-12
$65.00M
10-K · filed 2026-02-12
2024-09-30$19.00M
10-Q · filed 2025-11-04
$41.00M
derived: sum of 2 quarters · filed 2025-11-04
$45.00M
10-Q · filed 2025-11-04
$72.00M
derived: sum of 4 quarters · filed 2026-02-12
2024-06-30$22.00M
10-Q · filed 2025-08-05
$26.00M
10-Q · filed 2025-08-05
$53.00M
derived: sum of 3 quarters · filed 2026-02-12
$81.00M
derived: sum of 4 quarters · filed 2026-02-12
2024-03-31$4.00M
10-Q · filed 2025-05-06
$31.00M
derived: sum of 2 quarters · filed 2026-02-12
$59.00M
derived: sum of 3 quarters · filed 2026-02-12
$85.00M
derived: sum of 4 quarters · filed 2026-02-12
2023-12-31$27.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
$55.00M
derived: sum of 2 quarters · filed 2026-02-12
$81.00M
derived: sum of 3 quarters · filed 2026-02-12
$88.00M
10-K · filed 2026-02-12
2023-09-30$28.00M
10-Q · filed 2024-11-04
$54.00M
derived: sum of 2 quarters · filed 2024-11-04
$61.00M
10-Q · filed 2024-11-04
$79.00M
derived: sum of 4 quarters · filed 2025-02-13
2023-06-30$26.00M
10-Q · filed 2024-08-06
$33.00M
10-Q · filed 2024-08-06
$51.00M
derived: sum of 3 quarters · filed 2025-02-13
$68.00M
derived: sum of 4 quarters · filed 2025-02-13
2023-03-31$7.00M
10-Q · filed 2024-05-02
$25.00M
derived: sum of 2 quarters · filed 2025-02-13
$42.00M
derived: sum of 3 quarters · filed 2025-02-13
$57.00M
derived: sum of 4 quarters · filed 2025-02-13
2022-12-31$18.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13
$35.00M
derived: sum of 2 quarters · filed 2025-02-13
$50.00M
derived: sum of 3 quarters · filed 2025-02-13
$23.00M
10-K · filed 2025-02-13
2022-09-30$17.00M
10-Q · filed 2022-11-03
$32.00M
derived: sum of 2 quarters · filed 2022-11-03
$5.00M
10-Q · filed 2023-11-02
$20.00M
derived: sum of 4 quarters · filed 2024-02-13
2022-06-30$15.00M
10-Q · filed 2022-08-04
-$12.00M
10-Q · filed 2023-08-08
$3.00M
derived: sum of 3 quarters · filed 2024-02-13
$21.00M
derived: sum of 4 quarters · filed 2024-02-13
2022-03-31-$27.00M
10-Q · filed 2023-05-04
-$12.00M
derived: sum of 2 quarters · filed 2024-02-13
$6.00M
derived: sum of 3 quarters · filed 2024-02-13
$30.00M
derived: sum of 4 quarters · filed 2024-02-13
2021-12-31$15.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13
$33.00M
derived: sum of 2 quarters · filed 2024-02-13
$57.00M
derived: sum of 3 quarters · filed 2024-02-13
$20.00M
10-K · filed 2024-02-13
2021-09-30$18.00M
10-Q · filed 2022-11-03
$42.00M
derived: sum of 2 quarters · filed 2022-11-03
$5.00M
10-Q · filed 2022-11-03
$21.00M
derived: sum of 4 quarters · filed 2023-02-14
2021-06-30$24.00M
10-Q · filed 2022-08-04
-$13.00M
10-Q · filed 2022-08-04
$3.00M
derived: sum of 3 quarters · filed 2023-02-14
$22.00M
derived: sum of 4 quarters · filed 2023-02-14
2021-03-31-$37.00M
10-Q · filed 2022-05-05
-$21.00M
derived: sum of 2 quarters · filed 2023-02-14
-$2.00M
derived: sum of 3 quarters · filed 2023-02-14
$20.00M
derived: sum of 4 quarters · filed 2023-02-14
2020-12-31$16.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14
$35.00M
derived: sum of 2 quarters · filed 2023-02-14
$57.00M
derived: sum of 3 quarters · filed 2023-02-14
$78.00M
10-K · filed 2023-02-14
2020-09-30$19.00M
10-Q · filed 2021-11-04
$41.00M
derived: sum of 2 quarters · filed 2021-11-04
$62.00M
10-Q · filed 2021-11-04
$83.00M
derived: sum of 4 quarters · filed 2022-02-15
2020-06-30$22.00M
10-Q · filed 2021-08-05
$43.00M
10-Q · filed 2021-08-05
$64.00M
derived: sum of 3 quarters · filed 2022-02-15
$77.00M
derived: sum of 4 quarters · filed 2022-02-15
2020-03-31$21.00M
10-Q · filed 2021-05-06
$42.00M
derived: sum of 2 quarters · filed 2022-02-15
$55.00M
derived: sum of 3 quarters · filed 2022-02-15
$77.00M
derived: sum of 4 quarters · filed 2022-02-15
2019-12-31$21.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15
$34.00M
derived: sum of 2 quarters · filed 2022-02-15
$56.00M
derived: sum of 3 quarters · filed 2022-02-15
$73.00M
10-K · filed 2022-02-15
2019-09-30$13.00M
10-Q · filed 2020-11-05
$35.00M
derived: sum of 2 quarters · filed 2020-11-05
$52.00M
10-Q · filed 2020-11-05
$72.00M
derived: sum of 4 quarters · filed 2021-02-16
2019-06-30$22.00M
10-Q · filed 2020-08-06
$39.00M
10-Q · filed 2020-08-06
$59.00M
derived: sum of 3 quarters · filed 2021-02-16
$92.00M
derived: sum of 4 quarters · filed 2021-02-16
2019-03-31$17.00M
10-Q · filed 2020-05-06
$37.00M
derived: sum of 2 quarters · filed 2021-02-16
$70.00M
derived: sum of 3 quarters · filed 2021-02-16
$86.00M
derived: sum of 4 quarters · filed 2021-02-16
2018-12-31$20.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16
$53.00M
derived: sum of 2 quarters · filed 2021-02-16
$69.00M
derived: sum of 3 quarters · filed 2021-02-16
$81.00M
10-K · filed 2021-02-16
2018-09-30$33.00M
10-Q · filed 2019-11-07
$49.00M
derived: sum of 2 quarters · filed 2019-11-07
$61.00M
10-Q · filed 2019-11-07
$77.00M
derived: sum of 4 quarters · filed 2020-02-13
2018-06-30$16.00M
10-Q · filed 2019-08-06
$28.00M
10-Q · filed 2019-08-06
$44.00M
derived: sum of 3 quarters · filed 2020-02-13
$57.00M
derived: sum of 4 quarters · filed 2020-02-13
2018-03-31$12.00M
10-Q · filed 2019-05-02
$28.00M
derived: sum of 2 quarters · filed 2020-02-13
$41.00M
derived: sum of 3 quarters · filed 2020-02-13
$66.00M
derived: sum of 4 quarters · filed 2020-02-13
2017-12-31$16.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13
$29.00M
derived: sum of 2 quarters · filed 2020-02-13
$54.00M
derived: sum of 3 quarters · filed 2020-02-13
$68.00M
10-K · filed 2020-02-13
2017-10-01$13.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01
$38.00M
derived: sum of 2 quarters · filed 2018-11-01
$52.00M
10-Q · filed 2018-11-01
$65.00M
derived: sum of 4 quarters · filed 2019-02-14
2017-07-02$25.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02
$39.00M
10-Q · filed 2018-08-02
$52.00M
derived: sum of 3 quarters · filed 2019-02-14
$66.00M
derived: sum of 4 quarters · filed 2019-02-14
2017-04-02$14.00M
10-Q · filed 2018-05-02
$27.00M
derived: sum of 2 quarters · filed 2019-02-14
$41.00M
derived: sum of 3 quarters · filed 2019-02-14
$65.00M
derived: sum of 4 quarters · filed 2019-02-14
2016-12-31$13.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14
$27.00M
derived: sum of 2 quarters · filed 2019-02-14
$51.00M
derived: sum of 3 quarters · filed 2019-02-14
$64.00M
10-K · filed 2019-02-14
2016-10-02$14.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02
$38.00M
derived: sum of 2 quarters · filed 2017-11-02
$51.00M
10-Q · filed 2017-11-02
$67.00M
derived: sum of 4 quarters · filed 2018-02-15
2016-07-03$24.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08
$37.00M
10-Q · filed 2017-08-08
$53.00M
derived: sum of 3 quarters · filed 2018-02-15
$65.00M
derived: sum of 4 quarters · filed 2018-02-15
2016-04-03$13.00M
10-Q · filed 2017-05-04
$29.00M
derived: sum of 2 quarters · filed 2018-02-15
$41.00M
derived: sum of 3 quarters · filed 2018-02-15
$52.00M
derived: sum of 4 quarters · filed 2018-02-15
2015-12-31$16.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15
$28.00M
derived: sum of 2 quarters · filed 2018-02-15
$39.00M
derived: sum of 3 quarters · filed 2018-02-15
$47.00M
10-K · filed 2018-02-15
2015-09-27$12.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
$23.00M
derived: sum of 2 quarters · filed 2016-11-03
$31.00M
10-Q · filed 2016-11-03
$39.00M
derived: sum of 4 quarters · filed 2017-02-16
2015-06-28$11.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05
$19.00M
10-Q · filed 2016-08-05
$27.00M
derived: sum of 3 quarters · filed 2017-02-16
$37.00M
derived: sum of 4 quarters · filed 2017-02-16
2015-03-29$8.00M
10-Q · filed 2016-05-06
$16.00M
derived: sum of 2 quarters · filed 2017-02-16
$26.00M
derived: sum of 3 quarters · filed 2017-02-16
$34.00M
derived: sum of 4 quarters · filed 2017-02-16
2014-12-31$8.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16
$18.00M
derived: sum of 2 quarters · filed 2017-02-16
$26.00M
derived: sum of 3 quarters · filed 2017-02-16
$31.00M
10-K · filed 2017-02-16
2014-09-28$10.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
$18.00M
derived: sum of 2 quarters · filed 2015-11-05
$23.00M
10-Q · filed 2015-11-05
$29.00M
derived: sum of 4 quarters · filed 2016-02-24
2014-06-29$8.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
$13.00M
10-Q · filed 2015-08-06
$19.00M
derived: sum of 3 quarters · filed 2016-02-24
$25.00M
derived: sum of 4 quarters · filed 2016-02-24
2014-03-30$5.00M
10-Q · filed 2015-05-07
$11.00M
derived: sum of 2 quarters · filed 2016-02-24
$17.00M
derived: sum of 3 quarters · filed 2016-02-24
$37.00M
derived: sum of 4 quarters · filed 2016-02-24
2013-12-31$6.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24
$12.00M
derived: sum of 2 quarters · filed 2016-02-24
$32.00M
derived: sum of 3 quarters · filed 2016-02-24
$43.00M
10-K · filed 2016-02-24
2013-09-29$6.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
$26.00M
derived: sum of 2 quarters · filed 2014-11-10
$37.00M
10-Q · filed 2014-11-10
$47.00M
derived: sum of 4 quarters · filed 2015-02-27
2013-06-30$20.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12
$31.00M
10-Q · filed 2014-08-12
$41.00M
derived: sum of 3 quarters · filed 2015-02-27
$47.00M
derived: sum of 4 quarters · filed 2015-02-27
2013-03-31$11.00M
10-Q · filed 2014-05-13
$21.00M
derived: sum of 2 quarters · filed 2015-02-27
$27.00M
derived: sum of 3 quarters · filed 2015-02-27
$33.00M
derived: sum of 4 quarters · filed 2015-02-27
2012-12-31$10.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27
$16.00M
derived: sum of 2 quarters · filed 2015-02-27
$22.00M
derived: sum of 3 quarters · filed 2015-02-27
$28.00M
10-K · filed 2015-02-27
2012-09-30$6.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13
$12.00M
derived: sum of 2 quarters · filed 2013-11-13
$18.00M
10-Q · filed 2013-11-13
2012-07-01$6.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14
$12.00M
10-Q · filed 2013-08-14
2012-04-01$6.00M
10-Q · filed 2013-05-15
2011-12-31$19.00M
10-K · filed 2014-03-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
INSMED Inc (INSM)United States$26.566B-26.60
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64
Viatris Inc (VTRS)United States$20.008B-0.00
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10